UroLift System With SAbR for Prostate Cancer and BPH

Clinical Trials, Intermediate Risk Prostate Cancer, Low Risk Prostate Cancer

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT05311527
Phase: PHASE1
Trial Summary: Confirming safety of combining UroLift System prior to SAbR for patients with newly diagnosed prostate cancer and a history of BPH, by measuring the acute complication rate of UroL – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): University of Texas Southwestern Medical Center
Acronym:

Pin It on Pinterest